| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CymaBay Therapeutics, Inc. | 10%+ Owner | Pre-funded Warrant (right to buy) | 583,771 | 12 Sep 2023 | Indirect | ||
| CymaBay Therapeutics, Inc. | 10%+ Owner | Put Option (obligation to buy) | 950 | 13 Sep 2023 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000090266423004754-avoro-capital-advisors-llc-2023-09-12 | CymaBay Therapeutics, Inc. | 12 Sep 2023 | 5 | +$9,996,852 | 4 | 10%+ Owner | 14 Sep 2023, 12:53 |
| /report/000090266423000903-avoro-capital-advisors-llc-2023-01-26 | CymaBay Therapeutics, Inc. | 26 Jan 2023 | 1 | +$14,999,785 | 4 | 10%+ Owner | 30 Jan 2023, 15:30 |
| /report/000090266421005078-avoro-capital-advisors-llc-2021-11-22 | CymaBay Therapeutics, Inc. | 22 Nov 2021 | 1 | +$9,999,750 | 4 | 10%+ Owner | 23 Nov 2021, 15:15 |